(MOS) The Mosaic - Overview
Stock: Phosphate Fertilizers, Potassium Fertilizers, Animal Feed, Industrial Salts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.08% |
| Yield on Cost 5y | 4.20% |
| Yield CAGR 5y | 33.75% |
| Payout Consistency | 72.2% |
| Payout Ratio | 31.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.9% |
| Relative Tail Risk | -4.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | -5.75 |
| Character TTM | |
|---|---|
| Beta | 0.674 |
| Beta Downside | 0.895 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.67% |
| CAGR/Max DD | -0.27 |
Description: MOS The Mosaic January 02, 2026
The Mosaic Company (NYSE:MOS) is a vertically integrated producer and marketer of concentrated phosphate and potash nutrients, operating through three segments-Phosphates, Potash, and Mosaic Fertilizantes. Its asset base includes mines, chemical plants, blending and bagging facilities, port terminals, and warehouses across the United States, Brazil, Canada, Argentina, Paraguay, and a dozen other countries, enabling it to sell a broad portfolio that ranges from diammonium phosphate (DAP) and monoammonium phosphate (MAP) to K-Mag magnesia, animal-feed phosphates, and blended fertilizers to distributors, cooperatives, retailers, and industrial users worldwide.
Key performance indicators as of the latest fiscal year show ≈ 22 million metric tons of phosphate and ≈ 12 million metric tons of potash production, with revenue of roughly $13 billion and an adjusted EBITDA margin near 15 %. The business is highly sensitive to global fertilizer price cycles, which are driven by agricultural demand growth (estimated ≈ 2 % p.a. worldwide) and input cost pressures from natural gas (the primary feedstock for nitrogen-based products). Recent sector trends-such as tighter supply of potash due to geopolitical constraints in Russia and heightened focus on sustainable farming-have supported price premiums for Mosaic’s higher-value specialty products.
For a deeper, data-driven look at Mosaic’s valuation and risk profile, the ValueRay platform provides a concise, analyst-ready toolkit.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 1.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -2.12 > 1.0 |
| NWC/Revenue: 5.26% < 20% (prev 6.94%; Δ -1.68% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.10b > Net Income 1.23b |
| Net Debt (4.65b) to EBITDA (2.97b): 1.57 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (319.4m) vs 12m ago 0.0% < -2% |
| Gross Margin: 15.65% > 18% (prev 0.15%; Δ 1549 % > 0.5%) |
| Asset Turnover: 49.60% > 50% (prev 49.19%; Δ 0.42% > 0%) |
| Interest Coverage Ratio: 8.02 > 6 (EBITDA TTM 2.97b / Interest Expense TTM 237.6m) |
Altman Z'' 3.80
| A: 0.03 (Total Current Assets 5.08b - Total Current Liabilities 4.45b) / Total Assets 24.67b |
| B: 0.60 (Retained Earnings 14.85b / Total Assets 24.67b) |
| C: 0.08 (EBIT TTM 1.90b / Avg Total Assets 23.98b) |
| D: 1.09 (Book Value of Equity 12.76b / Total Liabilities 11.73b) |
| Altman-Z'' Score: 3.80 = AA |
Beneish M -2.99
| DSRI: 0.88 (Receivables 1.30b/1.43b, Revenue 11.89b/11.46b) |
| GMI: 0.99 (GM 15.65% / 15.45%) |
| AQI: 1.19 (AQ_t 0.23 / AQ_t-1 0.19) |
| SGI: 1.04 (Revenue 11.89b / 11.46b) |
| TATA: 0.01 (NI 1.23b - CFO 1.10b) / TA 24.67b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of MOS shares?
Over the past week, the price has changed by +4.88%, over one month by +8.01%, over three months by +11.48% and over the past year by +7.56%.
Is MOS a buy, sell or hold?
- StrongBuy: 5
- Buy: 7
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MOS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.3 | 13% |
| Analysts Target Price | 32.3 | 13% |
| ValueRay Target Price | 30.5 | 6.6% |
MOS Fundamental Data Overview February 03, 2026
P/E Forward = 12.0048
P/S = 0.7338
P/B = 0.6964
P/EG = 1.2191
Revenue TTM = 11.89b USD
EBIT TTM = 1.90b USD
EBITDA TTM = 2.97b USD
Long Term Debt = 3.37b USD (from longTermDebt, last quarter)
Short Term Debt = 1.25b USD (from shortTermDebt, last quarter)
Debt = 4.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.65b USD (from netDebt column, last quarter)
Enterprise Value = 13.38b USD (8.73b + Debt 4.80b - CCE 153.3m)
Interest Coverage Ratio = 8.02 (Ebit TTM 1.90b / Interest Expense TTM 237.6m)
EV/FCF = -65.68x (Enterprise Value 13.38b / FCF TTM -203.7m)
FCF Yield = -1.52% (FCF TTM -203.7m / Enterprise Value 13.38b)
FCF Margin = -1.71% (FCF TTM -203.7m / Revenue TTM 11.89b)
Net Margin = 10.33% (Net Income TTM 1.23b / Revenue TTM 11.89b)
Gross Margin = 15.65% ((Revenue TTM 11.89b - Cost of Revenue TTM 10.03b) / Revenue TTM)
Gross Margin QoQ = 16.00% (prev 17.25%)
Tobins Q-Ratio = 0.54 (Enterprise Value 13.38b / Total Assets 24.67b)
Interest Expense / Debt = 1.23% (Interest Expense 59.3m / Debt 4.80b)
Taxrate = 29.28% (175.5m / 599.3m)
NOPAT = 1.35b (EBIT 1.90b * (1 - 29.28%))
Current Ratio = 1.14 (Total Current Assets 5.08b / Total Current Liabilities 4.45b)
Debt / Equity = 0.38 (Debt 4.80b / totalStockholderEquity, last quarter 12.78b)
Debt / EBITDA = 1.57 (Net Debt 4.65b / EBITDA 2.97b)
Debt / FCF = -22.83 (negative FCF - burning cash) (Net Debt 4.65b / FCF TTM -203.7m)
Total Stockholder Equity = 12.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.13% (Net Income 1.23b / Total Assets 24.67b)
RoE = 10.14% (Net Income TTM 1.23b / Total Stockholder Equity 12.12b)
RoCE = 12.29% (EBIT 1.90b / Capital Employed (Equity 12.12b + L.T.Debt 3.37b))
RoIC = 8.13% (NOPAT 1.35b / Invested Capital 16.57b)
WACC = 5.73% (E(8.73b)/V(13.53b) * Re(8.40%) + D(4.80b)/V(13.53b) * Rd(1.23%) * (1-Tc(0.29)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.27%
Fair Price DCF = unknown (Cash Flow -203.7m)
EPS Correlation: -76.96 | EPS CAGR: -59.09% | SUE: -3.05 | # QB: 0
Revenue Correlation: -74.14 | Revenue CAGR: -2.81% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.52 | Chg30d=-0.193 | Revisions Net=-3 | Analysts=9
EPS next Year (2026-12-31): EPS=2.52 | Chg30d=-0.101 | Revisions Net=-4 | Growth EPS=-2.3% | Growth Revenue=+3.6%